Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1488-1489. doi: 10.1164/rccm.201701-0013LE.

Authors

Pennan M Barry¹, Phil Lowenthal¹, Lisa True¹, Leslie Henry¹, Gayle Schack¹, Kristen Wendorf¹, Jennifer Flood¹, Neha Shah^{1

2}

Affiliations

¹ 1 California Department of Public Health Richmond, California and.
² 2 Centers for Disease Control and Prevention Atlanta, Georgia.

PMID: 28665681
DOI: 10.1164/rccm.201701-0013LE

No abstract available

Publication types

Comment

MeSH terms

Antitubercular Agents*
California
Clinical Protocols
Humans
Mycobacterium tuberculosis
Tuberculosis, Multidrug-Resistant*

Substances

Antitubercular Agents